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Abstract 
Objective: Cleft lip with or without cleft palate (CL±P) or cleft palate (CP) are groups of 
malformations named orofacial clefts (OC), which are the second leading cause of birth 
defects. This study aimed to analyze clinical and epidemiological features of Brazilian 
patients with OC, studying cases treated in the reference center of the state of Paraná 
(PR).
Methods: 2,356 charts were reviewed and 1,838 were evaluated by the same clinical 
geneticist. Data were collected in the reference center, and compared with those of the 
Health Department of the state of Paraná. Clinical characteristics, presence of other 
anomalies, and birth prevalence were evaluated.
Results: 389 (21.2%) patients had CP, 437 (23.8%) had cleft lip (CL), and 1,012 (55%) had 
cleft lip and palate (CLP). Syndromic OC were identified in 15.3% of patients, 10.4% 
of patients with CL±P, and 33.9% of patients with CP. Common additional anomalies 
were: central nervous system, limbs, cardiovascular, and musculoskeletal defects. The 
number of syndromic cases was lower when clinical evaluation was performed by other 
medical specialists when compared to that of the clinical geneticist. Birth prevalence 
was 1/1,010 live births. Lack of notification with the national birth registry was observed 
in 49.9% of CL±P. The present data suggests a decrease of 18.52% in the prevalence of 
non-syndromic OC after folic acid fortification in Brazil.
Conclusion: Better understanding of clinical and epidemiological aspects of OC is crucial 
to improve the understanding of pathogenesis, promote preventive strategies, and guide 
clinical care, including the presence of clinical geneticists in the multidisciplinary team 
for OC treatment. 
© 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.  
Este é um artigo Open Access sob a licença de CC BY-NC-ND
Este é um artigo Open Access sob a licença de CC BY-NC-ND
138 Souza J & Raskin S
PALAVRAS-CHAVE
Fissura orofacial;
Fissura labiopalatina; 
Epidemiologia; 
Geneticista clínico; 
Brasil
Estudo clínico e epidemiológico de fissuras orofaciais
Resumo 
Objetivo: Fissura labial com ou sem fissura palatina (FL ± P) ou fissura palatina (FP) 
são grupos de malformações chamados fissuras orofaciais (FO) e são a segunda causa 
de defeitos congênitos. O objetivo do estudo foi analisar características clínicas e epi-
demiológicas de pacientes brasileiros com FO, estudando casos tratados no centro de 
referência do estado do Paraná (PR). 
Métodos: Foram analisados 2.356 gráficos. Destes, 1.838 foram avaliados pelo mesmo 
geneticista clínico. Os dados foram coletados no centro de referência e analisados na 
Secretaria de Estado da Saúde do Paraná. Foram avaliadas as características clínicas, a 
presença de outras anomalias e a prevalência de nascimentos.
Resultados: No total, 389 (21,2%) pacientes apresentaram fissura palatina (FP), 437 
(23,8%) apresentaram fissura labial (FL) e 1.012 (55%) apresentaram fissura labiopala-
tina (FLP). As FO sindrômicas foram identificadas em 15,3% dos pacientes, 10,4% dos 
pacientes com FL ± P, e 33,9% dos pacientes com FP. Anomalias comuns adicionais foram: 
sistema nervoso central, membros, sistema cardiovascular e sistema musculoesqueléti-
co. O número de casos sindrômicos foi menor nos centros em que a avaliação clínica foi 
realizada por outros especialistas, em comparação aos locais em que ela foi realizada 
por um geneticista clínico. A prevalência de nascimentos foi de 1/1.010 nascidos vivos. 
A ausência de notificação junto ao cartório de registro civil foi observada em 49,9% dos 
casos de FL ± P. No Brasil, nossos dados sugerem uma redução de 18,52% na prevalência 
de FO não sindrômicas após a fortificação com ácido fólico.
Conclusão: Um melhor entendimento dos aspectos clínicos e epidemiológicos das FO é 
fundamental para melhorar a compreensão de sua patogênese, promover estratégias de 
prevenção e promover orientações com relação a cuidados clínicos, com a presença de 
geneticistas clínicos na equipe multidisciplinar para tratamento de FO, por exemplo.
© 2013 Sociedade Brasileira de Pediatria. Publicado por Elsevier Editora Ltda.  
Introduction
Cleft lip with or without cleft palate (CL±P) and cleft palate 
(CP) are a group of malformations called orofacial clefts 
(OC), the second leading cause of congenital anomalies in 
live births.1 It is estimated that 1 to 2/1,000 live births 
have OC.2-4 Most patients with OC do not show any other 
abnormalities (non-syndromic OC), but a significant number 
(30% to 50%) have other malformations and can be part of 
a syndrome (syndromic OC).2,3
Non-syndromic OC is a group of malformations with 
multifactorial origin, in which genetic and environmental 
factors contribute to the etiology. Several studies have been 
conducted in order to expand knowledge of the etiology of 
isolated OC.5 The knowledge of etiologic factors, prevalence, 
and variable expression of this phenotype and its associated 
malformations can help in clinical management and patient 
approach, as well as contribute to a better understanding 
of its etiology and pathogenesis. 
Surveillance of congenital anomalies in Brazil is primarily 
performed through live birth declarations (LBDs). Since 1990, 
the Brazilian Ministry of Health established an information 
system on live births (ISLB) based on LBD.6 There is an open 
field on the LBD inquires for any congenital malformation; 
if positive, thefield is filled out. This field is supposed to 
be completed by a pediatrician, but in practice that rarely 
occurs.7 Also, until 2011, it could only be identified by a 
unique ICD-10 code. After 2011, the LBD allowed several 
ICD-10 codes, but this is still under implementation. 
Information based on LBD or ISLB is not reliable, due to lack 
of diagnosis, and omissions and misclassifications that occur 
both at the time of LBD completion and at the moment of 
entering and coding data.7
A second source of information for monitoring birth 
defects in Brazil is the network of hospitals working in 
collaboration with the Latin American Collaborative Study 
of Congenital Malformations (ECLAMC). However, Brazilian 
maternity hospitals that are part of ECLAMC cover less than 
2% of births in the country.8 According to ECLAMC, between 
the years 1982 to 2002, the birth prevalence of isolated OC 
was 1.5 per 1,000 live births.9 A third source of information 
is derived from centers for orofacial treatment, but the 
data collected in hospitals and clinics where patients are 
treated are strongly influenced by the socioeconomic status 
of the population attending these centers, as well as by the 
severity of defects.
This study aimed to describe the main clinical and 
epidemiological aspects of OC in the population of the state 
of Paraná, Southern Brazil. The information provided may 
be helpful to other clinicians involved in the treatment of 
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children with OC and to improve public health efforts in 
this area.
Material and methods
This study was approved by the Institutional Review Board 
of the Pontificia Universidade Católica do Paraná (PUC/PR), 
protocol No. 1015 from December, 2007). 
Patients with typical OC and born in the state of Paraná 
were included. Patients with atypical OC, submucosal cleft, 
and velopharyngeal incompetence were not included. 
Patients were selected in the the Centro de Atendimento 
Integral ao Fissurado Lábio Palatal (Assistance Center for 
Cleft Lip and Palate – CAIF), the state reference center for 
patients with craniofacial deformities. CAIF is an unit of 
the Health Department of Paraná (SESA), and is a member 
of the reference network for treatment of craniofacial 
deformities, created by the Brazilian Federal government 
in 1998 for accreditation of specialist services for treatment 
of craniofacial deformities.10 All care is provided by the 
Brazilian Unified Health System (Sistema Único de Saúde – 
SUS), and social and organization contributions.
Medical charts were reviewed and the subjects were 
divided in two groups: group 1 - all patients attended to by 
the same clinical geneticist from January, 2006 to January, 
2009, regardless of year of birth; and group 2 - all patients 
born between 2002-2008, and treated in CAIF. 
Group 1 was the group used to evaluate the presence 
or absence of other anomalies associated with OC, 
since all patients were evaluated by the same clinical 
geneticist. Data were collected including age, gender, 
place of birth, type of OC, presence of other anomalies, 
and family history. Classification of syndromic OC was 
assigned in patients presenting with at least one other 
major anomaly, or three or more minor anomalies beyond 
the OC, in accordance with Saal.1 The exception to this 
rule was the presence of a clearly known syndrome 
even without the major or minor anomalies, such as van 
der Woude syndrome. The associated anomalies were 
subdivided by systems: central nervous, urogenital, 
digestive, respiratory, musculoskeletal, limbs, 
cardiovascular, ocular, and integumentary. Also, the 
presence of intellectual disability was evaluated using 
the definitions of the American Association on Intellectual 
and Developmental Disabilities (AAIDD).11 
Group 2 was established to estimate the birth prevalence 
of OC in Paraná. The charts of all 1,198 patients attended 
to at CAIF who were born between the years 2002 to 2008, 
whether or not evaluated by the clinical geneticist, were 
reviewed. All patients were evaluated by a plastic surgeon 
and/or a pediatrician. Data were recorded including age, 
gender, place of birth, type of OC, and the presence of 
other anomalies. Information also was collected through 
the ISLB in SESA, and compared with CAIF data. The birth 
prevalence was estimated by dividing the higher number of 
live births with non-syndromic OC by the total live births 
registered during the period. Data from SESA was collected 
in January of 2010. Data on live births after this date 
may have changed due to late registration of birth or late 
treatment at CAIF. 
Descriptive analyses were conducted for the type of OC, 
age, gender, presence of associated anomalies, syndromic 
OC classification, and system involved in syndromic OC. To 
evaluate the association among the multiple parameters 
CL, CLP and CP, the chi-squared test was used. The odds 
ratio (95% confidence interval) was used to compare the 
type of OC and gender, and the birth prevalence of OC 
before and after wheat flour fortification with folic acid 
in Brazil. Values of p < 0.05 were considered statistically 
significant.
Results
The study included 2,356 patients: 1,838 from Group 1 
and 1,198 from Group 2. The latter included 680 patients 
evaluated and 518 patients not evaluated by the clinical 
geneticist. Mean age of patients at the time of evaluation 
for Group 1 was 12.9 years and the median was 9.9 years, 
ranging from 2 days to 87 years old. Of the 838 patients 
with OC, 389 (21.2%) had CP, 437 (23.8%) had CL, and 1,012 
(55%) had CLP. In patients with CL±P, 24.9% were bilateral: 
30.1% of those with CLP and only 12.8% of patients with 
CL (p < 0.001. When unilateral, CL±P was preferentially 
on the left side in 65.9% (p < 0.001). In patients with CP, 
the proportion of incomplete fissure was higher, affecting 
61.7% of cases (p < 0.001). Male gender was more prevalent 
in the total sample (55%, p < 0.001), comprising 60.4% of 
CL±P patients and 35% of CP (p < 0.001). When assessing 
CL±P, the ratio between males and females was 1.52 (95% 
CI: 1.37 to 1.69), while for CP the ratio was 0.54 (95% CI: 
0.44 to 0.66) (Table 1).
282 patients had syndromic OC (15.3% of the sample): 
10.4% and 10.3% of patients with CL and CLP, respectively, 
and 33.9% of patients with CP (p < 0.001 when comparing 
CL±P and CP, and no statistical difference for CL and CLP, 
Table 1). There was no significant difference between the 
syndromic diagnosis in cases with unilateral or bilateral 
OC (Table 2). Regarding gender and syndromic OC, it was 
observed that females were more associated with other 
anomalies than males in the total sample (p = 0.021). When 
analyzing OC types (CL±P and CP), 12.2% of females with 
CL±P had the diagnosis of syndromic OC, compared to only 
9.1% of males (p = 0.038). This was reversed for CP, where 
syndromic cases were observed mainly among males (43.4% 
versus 28.9%, p = 0.005, Table 2). 
Among all cases with syndromic OC, the most affected 
systems were: central nervous (33.3% of syndromic OC 
and 5.1% of the total sample), limbs (29.8% and 4.6%), 
cardiovascular (20.6% and 3.2%), and musculoskeletal 
(17.7% and 2.7%). Facial changes were observed in 
59.6% of cases. Most patients (87.2%) had more than one 
affected system. Some degree of intellectual disability 
was observed in 49.32% of syndromic cases (7.99% of the 
total sample). 
When selecting only the cases not evaluated by the clinical 
geneticist (n = 518), it was observed that the proportion of 
syndromic OC was 10.6% (24.4% for CP and 4% for CL±P, 
Table 1). Comparing this group with the group evaluated 
by the clinical geneticist, a difference was observed (p < 
0.001, Table 1) in diagnosing syndromic OC, demonstrating 
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a higher proportion in the group evaluated by the clinical 
geneticist.
Birth prevalence
Birth prevalence between the years 2002 and 2008 was 
1/1,010 live births (1/1,334 for CL±P and 1/3,953 for 
CP). Data provided by SESA are included in the table, and 
when this data is compared with that from CAIF, a lack of 
notification of 49.94% of CL±P cases is evidenced (Table 3). 
There was no sub-notification for CP.
When comparing the prevalence of non-syndromic OC to 
the period of onset of wheat flour fortification with folic 
acid in Brazil (July, 2004), a decrease of 18.52% of OC cases 
can be verified (OR = 0.81, CI 0.72 to 0.93, p = 0.002). That 
reduction was mainly for CL and CP in males, whereas there 
were decreases of 33.59% and 39.66% of cases, respectively 
(Table 4).
Discussion
Clinical characterization
The proportion of OC type is similar and relatively 
constant in most of published studies.2,12-14 The CL±P was 
unilateral in most cases. The left side was more affected, 
as reported in the literature.7,12-14 The reason for this 
predilection is not understood. Patterns of laterality in 
defects are known to be seen in various types of anomalies 
such as microtia, clubfoot, and congenital dysplasia of 
the hip.15 Groups of genes expressed asymmetrically 
during the early stages of embryonic development may 
contribute to this preference, however no study has 
demonstrated this yet. 
Patients with CLP had bilateral involvement twice as 
often as those with CL. This has also been reported by other 
authors,13,16 a fact that supports the hypothesis discussed in 
Table 1 Classification of orofacial clefts (OC) by severity, laterality, gender, and defect status.
Clinical presentation (patients evaluated by CL CLP CP 
the clinical geneticist, n = 1,838) n = 437 (23.8%) n = 1,012 (55%) n = 389 (21.2%)
Bilateral 56 (12.8%)a 305 (30.1%)a n/a
Unilateral 381 (87.2%)a 707 (69.9%)a n/a
Unilateral, right  122 (32%)b 249 (35.2%)b n/a
Unilateral, left  259 (68%)b 458 (64.8%)b n/a
Complete n/a n/a 149 (39.3%)
Incomplete n/a n/a 240 (61.7%)
Male 258 (59.04%)c 617 (60.97%)c 136 (35%)d
Female 179 (40.96%)c 395 (39.03%)c 253 (65%)d
Non-syndromic 392 (89.7%)e 907 (89.6%)e 257 (66.1%)e
Syndromic
Clinical geneticist 45 (10.3%)e 105 (10.4%)e,f 132 (33.9%)e,f
Pediatric/surgeon (n = 518) 5 (4%)e,f 9 (4%)e,f 41 (24.4%)e,f
CL, cleft lip; CL±P, cleft lip with or without cleft palate; CLP, cleft lip and palate; CP, cleft palate; n/a, not available.
aChi-squared analysis comparing the proportion of uni and bilateral defects between CL and CLP (p < 0.001).
bChi-squared analysis comparing the proportion of right and left involvement in unilateral CL±P (p < 0.001).
cChi-squared analysis comparing the proportion of male and female gender between CL and CLP (p < 0.001).
dChi-squared analysis comparing the proportion of male and female gender between CP (p < 0.001).
eChi-squared analysis comparing the proportion of syndromic OC between CL±P and CP (p < 0.001). There was no difference in 
proportion of syndromic OC between CL and CLP
fChi-squared analysis comparing the proportion of syndromic OC diagnosis between clinical geneticist and other medical specialists 
for CL±P and CP and (p < 0.001).
Table 2 Classification of syndromic orofacial clefts by laterality and gender.
Clinical presentation CL±P, n = 150 (10.4%) CP, n = 132 (33%) Total, n = 282 (15.3%)
Bilateral  42 (11.6%) n/a 42 (11.6%)a
Unilateral  108 (9.9%) n/a 108 (9.9%)a
Male 80 (9.1%)b 59 (43.4%)b 139 (13.7%)b
Female 70 (12.2%)b 73 (58.9%)b 143 (17.3%)b
CL±P, cleft lip with or without cleft palate; CP, cleft palate; n/a, not available.
aChi-squared analysis comparing the proportion of bilateral or unilateral CL±P not significant.
bChi-squared analysis comparing the proportion of male and female total cases (p = 0.021); of male and female CL±P cases (p = 
0.038); of male and female CP cases (p = 0.005)
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some studies that CL and CLP are pathogenetically distinct 
and should be analyzed separately.17 
Most patients with CL±P in this study were male, which 
is consistent with other reports.2,12-14 According to Croen et 
al.,3 CP is more frequent in females, a finding also observed 
in the present study. Gender-dependent susceptibility of 
OC is not well understood. According to Blanco et al.,18 
susceptibility of males to CL±P appears to be, at least 
partially, a consequence of the variation of the MSX1 
gene, located on chromosome 4. The hypothesis that genes 
related to the X chromosome should have an important role 
in the etiology of OC was also raised, but not confirmed.19 
Regarding CP, it is proposed that the timing of embryonic 
closure of the secondary palate is the reason for gender 
differences.20 In males, the merging and closing of the 
secondary palate occurs earlier than in females. This fact 
may have some relation to the increased incidence of CP 
in women.
Syndromic orofacial cleft
Data from other studies show great variability in the 
classification of syndromic cases, from 4.3% reported by 
Jensen et al.21 to 63.4% reported by Shprintzen et al.22 
This discrepancy is mainly due to the differences between 
the methodologies employed in classification and the lack 
of consensus on what should be considered a congenital 
defect associated with OC. Other factors are the training 
and experience of the professional responsible for the 
physical examination, and the fact that many authors do 
not report all individuals born in a particular location, 
instead only patients referred for treatment in a certain 
unit.2,4
An important finding was the difference observed in the 
presence of syndromic OC in relation to gender. Females 
with CL±P have more associated anomalies than males. 
This finding is the opposite for CP, in which the proportion 
Table 3 Non-syndromic orofacial clefts birth prevalence in Paraná – 2002 to 2008.
Year SESA Cases registered at CAIF Sub-notification Live births Birth prevalence
2002    165,125
Total 119 181 34.25%  1/912
CP 57 45 12.3%*  1/2,897
CL±P 62 136 54.41%  1/1,214
2003    157,333
Total 121 166 27.11%  1/947
CP 41 34 17.07% *  1/3,837
CL±P 80 132 41.67%  1/1,191
2004    159,636
Total 104 166 37.35%  1/962
CP 39 43 9.30%  1/3,712
CL±P 65 123 47.15%  1/1,297
2005    160,324
Total 97 153 36.60%  1/1,047
CP 41 43 4.65%  1/3,728
CL±P 56 110 49.09%  1/1,457
2006    153,598
Total 47 141 66.67%  1/1,089
CP 12 36 66.67%  1/4,266
CL±P 35 105 66.67%  1/1,462
2007    147,554
Total 94 151 37.75%  1/980
CP 37 39 5.13%  1/3797
CL±P 57 112 49.11%  1/1322
2008    151,437
Total 106 126 15.87%  1/1,201
CP 50 23 54% *  1/3,028
CL±P 56 103 45.63%  1/1,470
Total – 2002 to 2008    1,095,007
Total 688 1084 36.53%  1/1,010
CP 277 263 5.05% *  1/3,953
CL±P 411 821 49.94%  1/1,334
CAIF, Centro de Atendimento Integral ao Fissurado Lábio Palatal; CL±P, cleft lip with or without cleft palate; CP, cleft palate; SESA, 
Health Department of the State of Paraná.
*There was no subnotification.
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of males was more associated with other anomalies. This 
can be explained by the threshold theory of multifactorial 
disease, which observes that when a defect is less prevalent 
in a specific gender, abnormalities in patients of this gender 
are more severe and complex. 
Regarding the involvement of other systems, and 
considering all cases with syndromic OC, the most affected 
systems were: central nervous, limbs, cardiovascular, and 
musculoskeletal. Similar results were observed by Genisca 
et al.13 and Stoll et al.2 Most patients had more than one 
system affected, as also observed by Shprintzen et al.22 
Some degree of intellectual disability was observed in 
half of patients with syndromic OC. Strauss and Broder23 
also observed a high prevalence of intellectual disability 
among individuals with OC (10.1%), mainly mild and 
moderate intellectual disability (42.8% and 44.6% of this 
population, respectively). 
Regarding the classification of syndromic cases, a 
limitation of the study was the lack of karyotype in the 
majority of cases. This results from the lack of availability 
of such analysis through the public health system in 
this institution and in most public healthcare centers 
in Brazil. This is one factor that made the percentage 
of patients with chromosomal anomalies in the present 
study significantly lower than that reported by Tolarova 
and Cervenka14 and by Stoll et al.2 (4% versus 22.9% and 
21.3%, respectively). 
When comparing the percentage of syndromic OC diagnosis 
made by a clinical geneticist and by another medical 
specialist, it was observed that the diagnosis increases 
from 10.6% to 15.3%. The presence of a clinical geneticist is 
one of the international standards for care of OC patients.24 
According to Lin et al.25 a clinical geneticist trained in 
dysmorphology is able to differentiate the importance of 
facial features, body habitus, and development, which are 
essential for the diagnosis of cases with multiple congenital 
anomalies. Despite the importance of the presence of a 
medical geneticist on the team, Monlleó et al.10 observed 
that they were present in only 50% of the reference centers 
for the treatment of craniofacial deformities in Brazil. Their 
presence was even less common among other specialties of 
rehabilitation, surgery, and special care.
Birth prevalence
This study represents the first effort to estimate the 
birth prevalence of OC in Paraná. According to the CAIF 
records, the birth prevalence in Paraná was estimated in 
1 per 1,010 live births (0.99/1,000 births). Similar data 
were observed by Genisca et al.13 The prevalence of 
CL±P was 0.8/1,000 births and that of CP was 0.4/1,000 
births. Tolarova and Cervenka14 observed a prevalence 
of 0.77/1,000 for CL±P and 0.31/1,000 for CP. In Brazil, 
few studies have been conducted with this goal. Rezende 
and Zollner26 observed a birth prevalence of 1/672 live 
births in the city of Taubaté/São Paulo, and Nunes7 found 
1.35/1,000 live births in Campos dos Goytacazes/Rio de 
Janeiro. 
A significant sub-notification to the SESA/ISLB was 
observed. The fact that one in two live births with OC was 
not notified is worrisome, and this was surprisingly observed 
only for CL±P, an external anomaly easily observed at birth 
and sometimes even prenatally.27 Furthermore, this value 
may be underestimated, since some cases may not have been 
treated in CAIF. This lack of notification was not observed for 
CP, which is also unexpected, because CP is more difficult 
to diagnose at birth. Kubon et al.28 reported a lack of 
registration in Norway, and observed it was directly linked 
to the severity of the OC. These notified CP cases could be 
incorrectly classified, an observation made by Nunes,7 who 
found almost 100% of wrongly classified cases. 
Some recent publications suggest the importance of folic 
acid for the prevention of OC, but it is still controversial.9,29-31 
In Latin America, some countries have adopted a policy of 
Table 4 Non-syndromic orofacial clefts birth prevalence before and after wheat flour fortification with folic acid in Brazil 
(2002 to 2004 vs. 2006 to 2008).
 2002 to 2004 2006 to 2008 Decrease (%) Odds ratio 95% CI
     Inferior Superior
Total OC 513 418 18.52 0.81 0.72 0.93
CL±P 391 320 18.16 0.82 0.71 0.95
CP 122 98 19.67 0.80 0.62 1.05
CL 191 149 21.99 0.78 0.63 0.97
Male 131 87 33.59 0.66 0.51 0.87
Female 60 62 -3.33 1.03 0.72 1.47
CLP 200 171 14.50 0.86 0.70 1.05
Male 130 114 12.31 0.88 0.68 1.13
Female 70 62 11.43 0.89 0.63 1.25
CP 122 98 19.67 0.80 0.62 1.05
Male 58 35 39.66 0.60 0.40 0.92
Female 64 63 1.56 0.98 0.70 1.39
95% CI, 95% confidence interval; CL, cleft lip; CL±P, cleft lip with or without cleft palate; CLP, cleft lip and palate; CP, cleft 
palate; OC, orofacial clefts.
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food fortification with folic acid in order to reduce the 
incidence of neural tube defects. Brazil, through a resolution 
of Ministry of Health, made mandatory the fortification 
of wheat flour with 1.5 mg/kg of folic acid from July 1, 
2004 (RDC No.344 of 13/12/2002). The incidence of non-
syndromic OC patients treated at CAIF was evaluated and 
compared to the period of onset of wheat flour fortification 
with folic acid in Brazil; a decrease in cases of non-syndromic 
OC was observed, mainly for males with CL and CP. Tolarova 
was the first author to demonstrate the effect of folic acid 
on the incidence of OC;31 she showed a reduction of 65.4% 
in the recurrence of non-syndromic CL±P after multivitamin 
supplementation associated with high doses of folic acid (10 
mg). A meta-analysis by Johnson and Little32 observed that 
multivitamins during the periconceptional period decrease 
the risk of CL±P. However, there was no significant evidence 
showing that folic acid alone could decrease this risk. 
Recently, Lopez-Camelo et al.,9 through data from ECLAMC, 
evaluated the effect of food fortification with folic acid on 
the incidence of congenital anomalies in Brazil, Argentina, 
and Chile. There was no significant change in the number of 
cases of OC in any country. In the present study, it appears 
that wheat flour fortification with folic acid decreased the 
number of OC cases in Paraná. However, other variables 
that could also influence the incidence and recurrence of 
OC were not evaluated. 
Based on the present study, it can be estimated that 
approximately 20 new cases of OC are born in the state of 
Paraná per month, and most of them are not registered at 
the corresponding national agency. Most of these patients 
have non-syndromic OC, and evaluation by a clinical 
geneticist could improve the diagnosis of syndromic cases. 
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